CDC Report Highlights Rising Drug-Resistant Threats

New agency data reveals 19 resistant germs cause millions of annual infections across the United States.

Updated on Oct. 27, 2026 in COVID-19

Bold flat-color editorial illustration of a crystalline bacterial structure, representing the serious scale of drug-resistant health threats. — The CDC's 2026 report identifies 19 antibiotic-resistant pathogens causing over nine million annual infections across the United States. AI Illustration. Upload story photo >

Live Poll

Do you trust the U.S. healthcare system to effectively manage the rise of drug-resistant infections?

The Centers for Disease Control and Prevention released its 2026 AR Threats Report, detailing the impact of drug-resistant pathogens in the United States. Nineteen specific germs are responsible for 9.7 million infections and 50,800 deaths annually.

Why it matters

Understanding the prevalence of these pathogens is essential for tracking progress in infection prevention and antibiotic stewardship. The findings underscore the evolving landscape of medical threats as specific bacteria shift in their classification and severity.

In 2023, health care-associated infections resulted in over 42,000 deaths and nearly $12 billion in costs. Additionally, Candida auris infections have increased tenfold since 2019.

The players

Centers for Disease Control and Prevention

This federal agency is the national public health institute of the United States.

The details

The report highlights that bacterial threats share resistance through mobile genetic elements. While some areas see improvement, such as a 21% decrease in Clostridioides difficile rates between 2018 and 2020, other threats like Neisseria meningitidis have been newly added to the watch list.

Clostridioides difficile rates dropped 21% between 2018 and 2020.
Candida auris infections serve as a baseline for the tenfold increase since 2019.
Deaths and costs from health care-associated infections were calculated for 2023.
The Centers for Disease Control and Prevention released the AR Threats Report in 2026.

The Big Picture

This story updates the baseline established by the Centers for Disease Control and Prevention AR Threats Report. It tracks how medical threats evolve relative to the agency's established surveillance standards for antibiotic resistance.

Patients may see changes in hospital infection prevention protocols due to the updated risk assessment for resistant germs. Increased attention to antibiotic stewardship could shift treatment approaches for common infections.

The takeaway

Public health efforts to reduce infection rates, such as the successful management of C. diff, demonstrate the efficacy of coordinated diagnostic and preventative measures. Ongoing vigilance remains necessary as pathogens adapt and move through health care systems.